Anthrax Vaccine Trial Of 1,500 Patients Could Begin In Summer 2000
An anthrax vaccine study involving 1,500 patients could begin as early as this summer.
You may also be interested in...
President Clinton's tax credit to encourage the development of vaccines for targeted diseases would be based on sales to nonprofit organizations rather than the amount spent on research and development.
The Department of Defense will develop a protocol on the use of investigational drugs on military personnel that will incorporate the President's executive order and FDA's interim rule on seeking informed consent waivers. The protocol is expected by early next year.
A longitudinal cohort study to determine the efficacy of Lansing, Michigan-based Bioport's anthrax vaccine adsorbed would be conducted under a proposal by Army Surgeon General Ronald Blank.